Cyclo Therapeutics Correlations

CYTHW Stock

USD 0.09 0.03 23.33%

The current 90-days correlation between Cyclo Therapeutics and Alto Ingredients is -0.12 (i.e., Good diversification). The correlation of Cyclo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cyclo Therapeutics Correlation With Market

Average diversification

The correlation between Cyclo Therapeutics and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more information on how to buy Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.

Moving together with Cyclo Stock

0.66	VOR	Vor Biopharma	Pair Corr
0.66	RGEN	Repligen	Pair Corr
0.63	ELMD	Electromed	Pair Corr
0.61	AMN	AMN Healthcare Services	Pair Corr
0.71	INGN	Inogen Inc	Pair Corr
0.69	NPCE	Neuropace	Pair Corr
0.62	NYXH	Nyxoah	Pair Corr
0.72	TMCI	Treace Medical Concepts	Pair Corr

Moving against Cyclo Stock

0.56	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.51	SGHT	Sight Sciences	Pair Corr
0.31	PKX	POSCO Holdings	Pair Corr

Related Correlations Analysis

	AXTA	APD	ALTO	PKE	SXT	EGO	HDSN	IIIN
AXTA		0.76	0.25	0.53	0.53	-0.2	-0.04	0.7	AXTA
APD	0.76		0.26	0.35	0.43	-0.25	0.07	0.48	APD
ALTO	0.25	0.26		0.37	-0.31	-0.17	0.07	-0.07	ALTO
PKE	0.53	0.35	0.37		0.53	0.34	-0.21	0.3	PKE
SXT	0.53	0.43	-0.31	0.53		0.25	-0.1	0.51	SXT
EGO	-0.2	-0.25	-0.17	0.34	0.25		0.05	-0.22	EGO
HDSN	-0.04	0.07	0.07	-0.21	-0.1	0.05		-0.19	HDSN
IIIN	0.7	0.48	-0.07	0.3	0.51	-0.22	-0.19		IIIN
	AXTA	APD	ALTO	PKE	SXT	EGO	HDSN	IIIN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

APD	+ 0.76	AXTA
IIIN	+ 0.7	AXTA
PKE	+ 0.53	AXTA
SXT	+ 0.53	AXTA
SXT	+ 0.53	PKE
IIIN	+ 0.51	SXT

High negative correlations

SXT	- 0.31	ALTO
EGO	- 0.25	APD
IIIN	- 0.22	EGO
HDSN	- 0.21	PKE
EGO	- 0.2	AXTA
IIIN	- 0.19	HDSN

Risk-Adjusted Indicators

There is a big difference between Cyclo Stock performing well and Cyclo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cyclo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AXTA	1.40	(0.09)	0.00	(0.14)	0.00	0.00	2.13	(3.07)	12.04
APD	1.12	(0.04)	0.00	(0.12)	0.00	0.00	2.38	(1.85)	8.35
ALTO	3.48	0.05	0.00	(0.02)	0.00	0.00	9.70	(6.00)	19.74
PKE	1.33	(0.04)	0.00	(0.12)	0.00	0.00	2.27	(2.98)	7.97
SXT	1.20	(0.02)	0.00	(0.09)	0.00	0.00	2.33	(2.24)	11.22
EGO	1.99	0.03	0.02	0.01	3.48	(1.84)	4.42	(5.33)	16.79
HDSN	1.56	0.18	0.11	0.26	1.74	(1.87)	3.42	(3.02)	8.73
IIIN	1.76	(0.03)	0.00	(0.09)	0.00	0.00	3.32	(3.15)	14.41

Cyclo Therapeutics Corporate Management

Michael Lisjak	Global Development	Profile
George Fails	Ex Mang	Profile
Jeffrey Tate	Chief COO	Profile
Scott Fine	CEO Director	Profile
Lori McKenna	Global Advocacy	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC